Position in DGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,190,059
+$181,571 QoQ
Shares Held
15,051
-2.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#317
of 1,090 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $40,569,660 across 16 Diagnostics & Research names. DGX ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
13,026 | $6,530,715 | |
| 2 | ILMN |
Illumina, Inc.
|
22,808 | $4,010,330 | |
| 3 | DHR |
Danaher Corp /De/
|
19,635 | $3,740,074 | |
| 4 | DGX |
Quest Diagnostics Inc
This page
|
15,051 | $3,190,059 | |
| 5 | A |
Agilent Technologies, Inc.
|
23,182 | $3,079,265 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
13,010 | $2,950,537 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
14,384 | $2,779,276 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
4,777 | $2,514,803 |
All Filings in DGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,190,059 | 15,051 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,008,488 | 15,351 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,019,368 | 11,637 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,340,322 | 12,280 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $946,290 | 5,268 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $674,092 | 3,984 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $275,621 | 1,827 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $321,833 | 2,073 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $368,617 | 2,693 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||